Psychedelic compounds, including psilocybin, LSD, DMT, and 5-MeO-DMT all of which are
serotonin (5-HT) 2A receptor agonists are being investigated as potential treatments. This …

Psychedelic microdosing is the practice of taking very low doses of psychedelic substances,
typically over a longer period of time. The long-term safety of chronic microdosing is …

Classical serotonergic psychedelics such as lysergic acid diethylamide (LSD) or the
naturally occurring compounds psilocybin and mescaline produce profound changes in …

Psychotherapies assisted by psychedelic substances have shown promising results in the
treatment of psychiatric disorders. The aim of this systematic review and meta-analysis was …

Ibogaine (IBO) is an atypical psychedelic with a complex mechanism of action. To date, the
mechanisms that may underlie its anti-addictive effects are still not defined. This study aims …

Background: Psychedelic-assisted therapy (PAT) is permitted in Switzerland under its limited
medical use program. Data from patients in this program represent a unique opportunity to …

Background: Research with the Psychedelic Experience Questionnaire/Scale (PES) focuses
on questions relating to mystical experience (Mystical Experience Questionnaire (MEQ)) …

Background There has been renewed interest in the use of 3, 4-methylenedioxy-
methamphetamine (MDMA) and serotonergic psychedelics in the treatment of multiple …

Psychedelics are powerful psychoactive substances that alter perception and mood
processes. Their effectiveness in the treatment of psychiatric diseases was known before …

The pharmacodynamic effects of lysergic acid diethylamide (LSD) are diverse and different
in different individuals. Effects of other psychoactive substances have been shown to be …